Tianjin University of Traditional Chinese Medicine
Also known as: First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine | First Teaching Hospital of Tianjin University of Traditional Chinese Medicine | Second Affiliated Hospital of Tianjin University of TCM | Second Teaching Hospital of Tianjin University of Traditional Chinese Medicine | The First Affiliated Hospital of Tianjing University of Traditional Chinese Medicine | The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine | The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine，China | Tianjin Nankai Hospital | Tianjin University of Traditional Chinese Medicine
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2006Last known activity
Dec 25, 2025
Timeline
1950s
- Jun 1, 1958
Tianjin University of Traditional Chinese Medicine— Founded
Drugs by trial phase (49 distinct, 35 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Other trials (28 own, 0 via acquisition)
Indications
Studied for
- Acute-On-Chronic Liver Failure
- Arthritis
- Arthritis, Rheumatoid
- Cerebral Infarction
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Disease
- End Stage Liver Disease
- Gastroesophageal Reflux
- Hepatic Insufficiency
- Hypersensitivity
- Ischemia
- Kidney Diseases
- Liver Failure
- Liver Failure, Acute
- Pancreatitis
- Pancreatitis, Acute Necrotizing
- Pelvic Infection
- Pelvic Inflammatory Disease
- Prostatic Neoplasms
- Renal Insufficiency, Chronic
- Stroke
- Tic Disorders
- Tics
- Tourette Syndrome
Recent trials (50)
- NCT07296614CollaboratorPhase 3Dec 25, 2025
- NCT06009991CollaboratorN/AJul 17, 2023
- NCT05792813CollaboratorEarly Phase 1Jun 30, 2023
- NCT05741047CollaboratorN/AMar 7, 2023
- NCT05741047Overall official - principal investigatorN/AMar 7, 2023
- NCT05172531Lead sponsorN/AAug 29, 2022
- NCT05172531Reponsible party - principal investigatorN/AAug 29, 2022
- NCT05053763Sponsor investigatorN/AOct 10, 2021
- NCT04969068Lead sponsorPhase 4Aug 31, 2021
- NCT04969068Reponsible party - principal investigatorPhase 4Aug 31, 2021
- NCT04873479Reponsible party - principal investigatorN/AMay 10, 2021
- NCT04873479Study chairN/AMay 10, 2021
- NCT04873479Lead sponsorN/AMay 10, 2021
- NCT04815265Study chairPhase 4Apr 1, 2021
- NCT04815265Reponsible party - principal investigatorPhase 4Apr 1, 2021
Details
- Founded
- Tianjin, CN Jun 1, 1958
- Last known activity
- Dec 25, 2025